InvestorsHub Logo
Followers 45
Posts 1686
Boards Moderated 0
Alias Born 11/28/2018

Re: None

Wednesday, 10/21/2020 1:03:27 PM

Wednesday, October 21, 2020 1:03:27 PM

Post# of 233137
This is a bone of contention maybe someone can answer. I know NP said we are going to try Philippines and the U.K. for severe and critical. Like Rockleo says if you don’t unblind any results as far as deaths go how are they supposed to approve with no info other than the DSMC recommendation to continue trial as is no changes. Would either country take a chance with no unblinding data to approve it in their country? My thought is it’s like playing the lottery and hoping for a jackpot or lucky break. In the near term only major catalyst is MHRA approval in meeting on the 26th. Another long shot for combo. Until then we went from 5 big pharma companies to 11 to zero. Nader flips his script like flipping burgers. Go back and listen to past CCs and when you compare, you see he is all over the place. No two statements are ever the same. The message is never clear. Slideshows show paths and glad he said they won’t continue with mild to moderate trial and will focus on long haulers which makes lots of sense. That is the bread and butter in my opinion. It holds the most promise for use of Leronlimab and no one is even addressing this. GLTA. For those on this board whose family members are sick and maybe exposed, or who have lost loved ones my sincerest condolences and God bless. Saying prayers for speedy recovery.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News